pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 3
    ibudilast
    ibudilast [INN]
    Amyotrophic Lateral Sclerosis$MNOV MEDICINOVA INC
  • Marketed
    ibuprofen lysine
    Neoprofen (ibuprofen lysine)
    Patent Ductus Arteriosus Recordati Rare Diseases Inc
  • Phase 3
    ibutamoren mesylate
    Oratrope (ibutamoren mesylate)
    Growth Hormone Deficiency Lumos Pharma Inc
← prev
page 185 of 231
next →
Pain89
Neurology1
Marketed
ibutilide fumarate
Ibutilide Fumarate
Atrial Fibrillation
American Regent Inc
  • Phase 3
    ibuzatrelvir
    ibuzatrelvir
    Coronavirus Disease 2019 (COVID-19)$PFE PFIZER INC
  • Marketed
    icatibant acetate
    Firazyr (icatibant acetate)
    Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN… Takeda Pharmaceuticals USA Inc
  • Marketed
    icosapent ethyl
    Alfa (icosapent ethyl)
    Familial Adenomatous Polyposis KD Pharma Group SA
  • Phase 2
    icovamenib
    icovamenib
    Type 2 Diabetes$BMEA Biomea Fusion, Inc.
  • Marketed
    idarucizumab
    Praxbind (idarucizumab)
    Bleeding And Clotting Disorders Boehringer Ingelheim Corp
  • Marketed
    idecabtagene vicleucel
    Abecma (idecabtagene vicleucel)
    Refractory Multiple Myeloma Celgene Corp
  • Phase 2
    idroxioleic acid
    idroxioleic acid
    Malignant Glioma Laminar Pharmaceuticals SA
  • Marketed
    idursulfase
    Elaprase (idursulfase)
    Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Shire Human Genetic Therapies Inc
  • Phase 2
    ifenprodil
    ifenprodil [INN]
    Chronic Cough Seyltx Inc
  • Phase 2
    ifetroban
    Dyscorban (ifetroban)
    Duchenne Muscular Dystrophy$CPIX CUMBERLAND PHARMACEUTICALS INC
  • Phase 2
    ifezuntirgene inilparvovec
    ifezuntirgene inilparvovec [INN]
    Huntington Disease UniQure NV
  • pre_registration
    ifinatamab deruxtecan
    ifinatamab deruxtecan
    Small-Cell Lung Cancer Daiichi Sankyo Co Ltd
  • Phase 2
    ignaseclant
    ignaseclant
    Myasthenia Gravis NMD Pharma AS
  • Marketed
    iloperidone
    Fanapt (iloperidone)
    Bipolar I Disorder$VNDA Vanda Pharmaceuticals Inc.
  • Phase 3
    iltamiocel
    iltamiocel
    Stress Urinary Incontinence Cook MyoSite Inc
  • Phase 2
    imapextide sodium LA
    imapextide sodium
    Hypoglycemia$MBX MBX Biosciences, Inc.
  • Phase 2
    imdusiran sodium
    imdusiran sodium
    Hepatitis B$ABUS Arbutus Biopharma Corp
  • Phase 2
    imeglimin
    imeglimin [INN]
    Type 2 Diabetes Poxel SA
  • Phase 3
    imeroprubart
    imeroprubart
    Rheumatoid Arthritis$IMVT Immunovant, Inc.
  • Phase 2
    imifoplatin
    imifoplatin
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Promontory Therapeutics Inc
  • Marketed
    imipramine
    Imipramine Hydrochloride (imipramine [INN])
    Enuresis Oxford Pharmaceuticals LLC
  • pre_registration
    imlifidase
    Idefirix (imlifidase)
    Kidney Transplant Rejection Hansa Biopharma AB
  • Phase 2
    imneskibart
    imneskibart
    Colorectal Cancer Aulos Bioscience Inc
  • pre_registration
    imsidolimab
    imsidolimab
    Generalized Pustular Psoriasis (GPP)$VNDA Vanda Pharmaceuticals Inc.
  • Phase 2
    imzokitug
    imzokitug
    Colorectal Cancer Bristol-Myers Squibb Co
  • Marketed
    inamrinone
    Amrinone Lactate (inamrinone)
    Congestive Heart Failure (Heart Failure) Hikma Pharmaceuticals USA Inc